Also das mit den 120.000,-USD Aktien von CEO Dodd kann ich aufklären, stand so in gleicher Diktion in dem Antwortbrief an die Beteiligten von Shane Skinners Petition, hatte ich damals auch bekommen und ist gewissermaßen ein alter Hut, nix Neues. Den auf dem US message board geposteten Antwortbrief, angeblich von general counsel and vice president Phil Theodore, nehme ich ihm so fast ab, in einer natürlichen Klarheit und Ehrlichkeit, freilich wissen können wir's nicht. Tagesaktuell spannender finde ich den heutigen Post von Daniel Ward auf Seeking Alpha, auch fundierte Kritiker sollen hier zu Wort kommen:
The company will need to pay of the Series A Warrant holders on the next dilution, which will be pricy. Costs to close the Canadian office (benefits, severance-type payouts, etc.) should not be ignored, and you make a good point regarding that being relevant. The time to review this stock for possible investment is exactly what you say: after the RS and after the next dilution (presumably Q2/Q3 next year when the dilution will be I would guess). I actually was going to write a new article, but management cover the major aspect I would have been highlighting with its Friday PR. This aspect was that they were between a rock and a hard place regarding staying on the NASDAQ. We'll see how things develop. Eventually the stock will not be a sell, but at this point it certainly is still a sell. Good luck! |